Chemotherapy: Global castrate resistant prostate cancer market statistics, 2016-2027 (USD Million)
Global chemotherapy castrate-resistant prostate cancer market size was valued at 580.0 USD million in 2017 and is estimated to grow at a compound annual growth rate (CAGR) of 8% from 2018 to 2027.